SOLICITATION NOTICE
D -- FDA DATA DASHBOARDS & ANALYTICS
- Notice Date
- 1/21/2021 4:11:41 AM
- Notice Type
- Presolicitation
- NAICS
- 541519
— Other Computer Related Services
- Contracting Office
- FOOD AND DRUG ADMINISTRATION ROCKVILLE MD 20857 USA
- ZIP Code
- 20857
- Solicitation Number
- FDA-RFI-21-0605
- Response Due
- 1/25/2021 12:00:00 PM
- Archive Date
- 01/27/2021
- Point of Contact
- Michele Andrews
- E-Mail Address
-
michele.andrews@fda.hhs.gov
(michele.andrews@fda.hhs.gov)
- Description
- Food and Drug Administration Request for Information For FDA�s Data Dashboard Requirements Anticipated Contract Type: �Blanket Purchase Agreement (BPA) Summary This Sources Sought / Request for Information (RFI) is issued in support of the anticipated acquisition of the Food and Drug Administration�s procurement of services and licenses for the operation, maintenance and improvement of a public-facing data dashboard solution. It is anticipated that this requirement will result in the award of a Blanket Purchase Agreement (BPA) and, based on the responses to this Sources Sought / RFI, the FDA will be able to determine the appropriateness of small business participation. Background This Sources Sought / RFI is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. �The purpose of this RFI is to help the FDA understand the industry best practices and technical solutions capable of providing the full range of services described in this RFI and the draft SOW. �FDA will use this market research information to assess the market�s capability to successfully meet FDA�s Dashboard requirements. � FDA welcomes responses from all interested parties. FDA does not intend to make a selection decision or award a contract on the basis of RFI responses nor otherwise pay for the preparation of any information submitted or FDA�s use of such information. �Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. �Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. �However, FDA reserves the right to contact vendors if additional information is required. The FDA is requesting comments on the draft SOW from both large and small businesses. Comments from all sized firms are welcome. �In addition, the purpose of this Sources Sought / RFI is to obtain industry comments on the draft Statement of Work (SOW) and determine the acquisition strategy regarding small business participation. �Through the RFI process, the FDA is requesting information about the capabilities and past performance of contractors interested in providing these services across the FDA. �Interested small business contractors including Small Disadvantaged Business, Women-Owned, 8(a)�s, HUBZones, Veteran-Owned, or Service-Disabled Veteran-Owned Small Businesses are encouraged to respond. � General Instructions A complete response to the RFI should include answers to all of the questions below. � �Responses should demonstrate capability, not merely affirm the respondent�s capability (e.g.: The response must go beyond the statement that, �XYZ company can provide a dashboard tool.�). ��� �Instructions for All Businesses: �In addition to answering the questions included in the RFI, interested parties are encouraged to submit comments and suggestions related to the draft Statement of Work. �Please submit response in Microsoft Word or PDF format. �All information submitted, including responses to RFI questions and any comments and suggestions for the SOW should not exceed ten (10) one-sided 8 � x 11 pages, with one inch margins, and font no smaller than 12 point. ��� �Further instructions for Small Businesses: In addition to RFI answers and comments and suggestions to the draft Statement of Work outlined above, small business respondents shall include the information required in items 1-3 below. �Please submit response in Microsoft Word or PDF format. �Any company proprietary information must be marked as such. �This Small Business information is in addition to the �Instructions for All Businesses� detailed above and should not exceed three (3) one-sided 8 � x 11 pages, with one-inch margins, and font no smaller than 12 point. �This brings the total page limitation for small businesses to thirteen (13) one-sided 8�11 pages (including the ten (10) pages of comments as referenced above). ��� �Small Business Item 1. �Company name, address, telephone number, a point of contact with e-mail address, and Data Universal Numbering System (DUNS) number. �Indicate small business size status, if applicable, including status as a Small Disadvantaged Business, 8(a), Woman-Owned, HUBZone, Veteran-Owned, or Service Disabled Veteran-Owned Small Business. ��� �Small Business Item 2. �A summary of the company�s past performance providing services of similar size and scope, similar to those identified in the attached Draft Statement of Work during the past three years, including any on-going contracts. �Include contracting activities/agencies, contract numbers, contract value, contract period of performance, number of labor hours provided during the period of performance, the number of locations covered by each contract, whether your company served as a prime contractor or subcontractor, and a point of contact at the contracting activity who can verify the information you provided.� ��� �Small Business Item 3. �Additionally, please demonstrate your firm�s capability to meet the requirements of FAR 52.219-14, Limitations on Subcontracting. Responses should be emailed to Michele E. Andrews, Contracting Officer at Michele.Andrews@fda.hhs.gov no later than 3:00 PM (noon) Eastern Time, January 25, 2020. Questions to be answered by all Businesses, regardless of size: The purpose of this Statement of Work is to convey the current FDA organization�s objectives, applicable scope, and task areas as related to the operation of a public-facing data dashboard. �Individual task orders will be issued to obtain specific public-facing dashboard toolset services. �The representative technology described in the SOW is comprehensive and is intended to provide an overall understanding of the public-facing dashboard toolset technologies employed by the FDA and level of expertise and capabilities sought for a contract.� 1.�� �Please provide the following: a.�� �Organization name b.�� �Length of time the Organization has been in business c.�� �Types of services provided by your Organization; d.�� �Types of clients by industry (i.e. Federal, Commercial, Local Government, etc.); e.�� �Is the Organization, U.S. based or International;� f.�� �Is the Organization a subsidiary of another Organization;� g.�� �DUNS number� h.�� �Organization�s website i.�� �Contact Name j.�� �Contact Telephone k.�� �Contact E-mail address l.�� �Size designation m.�� �Number of employees in your organization n.�� �Your organization�s current and gross revenue� o.�� �SBA size designation information and small business concern type (if applicable); p.�� �Number of employees in the organization;� q.�� �Organization�s most recent annual receipts amount as defined by the SBA. r.�� �Web address of public-facing data dashboards implemented within the past three years. 2.�� �Does your organization have an existing GSA schedule for the types of software/services outlined in the draft SOW? �If so, please provide the information.� 3.�� �Please describe your capability and experience with designing, building, and maintaining custom public-facing dashboard solutions. 4.�� �Please describe your capability and experience with acquiring, maintaining, and using Qlik Sense Business Intelligence software for the development of public-facing data dashboard(s). 5.�� �Please describe your capability and experience with acquiring, maintaining, and using Amazon Web Services and GovCloud for hosting public-facing data dashboard. 6.�� �Please describe your capability and experience with designing, building, and maintaining custom extract, transform, load (ETL) process and ETL processes incorporating ColdFusion components for the data management of public-facing data dashboard(s). 7.�� �How would you optimize your public-facing dashboard solution to allow significant and variable rate of access by concurrent users to a public-facing dashboard, from less than 5 to over 1,000?� 8.�� �How would you optimize the system to allow users to access and analyze large amounts of data, over a million rows? 9.�� �How would you optimize the system to allow for an ever-increasing data size, including mapping and merging various sources of data and integrating the results? 10.�� �Please describe your organization�s capability in the task areas provided in the statement of work. 11.�� �Please describe your experience transitioning as the new contractor on an existing project. �Please describe the focus of your team for the first 100 days. 12.�� �Is the scope of the draft BPA SOW clearly defined? �Do you understand what FDA requires? �If not, what information needs to be added, changed, and/or reworded in order to clarify the Government�s requirements? �Please provide the referenced SOW sections and page numbers with your response. ��� �Please note any additional considerations your company suggests critical to this procurement. Attachment: 1.�� �Draft BPA SOW�
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/7020f5c3d5d247818ae206e3f1919d20/view)
- Record
- SN05896625-F 20210123/210121230103 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |